Hepatitis A-hepatitis B vaccine - GlaxoSmithKline

Drug Profile

Hepatitis A-hepatitis B vaccine - GlaxoSmithKline

Alternative Names: Ambirix; Twinrix; Twinrix Adult; Twinrix Paediatric; Twinrix® Junior

Latest Information Update: 06 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Hepatitis A vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis A; Hepatitis B

Most Recent Events

  • 03 Aug 2015 Withdrawn for Hepatitis A (Prevention) in Brazil (IM) before August 2015
  • 03 Aug 2015 Withdrawn for Hepatitis A (Prevention, In adolescents, In children, In infants) in Brazil (IM) before August 2015
  • 03 Aug 2015 Withdrawn for Hepatitis B (In adolescents, In children, In infants, Prevention) in Brazil (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top